1. The role of Tau protein in resistance to paclitaxel

   • Marta Smoter
   • Lubomir Bodnar
   • Cezary Szczylik

   Mini Review Open access 29 June 2011 Pages: 553 - 557

2. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells

   • Masakazu Hamada
   • Tetsuei Miki
   • Yoshiaki Yura

   Original Article 25 November 2010 Pages: 559 - 569

   

3. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy

   • Niranjan Awasthi
   • Margaret A. Schwarz
   • Roderich E. Schwarz

   Original Article 26 November 2010 Pages: 571 - 582

   

4. Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells

   • Anna Fyrberg
   • Curt Peterson
   • Kourosh Lotfi

   Original Article 26 November 2010 Pages: 583 - 591

   

5. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

   • Izet M. Kapetanovic
   • Miguel Muzzio
   • David L. McCormick

   Original Article 30 November 2010 Pages: 593 - 601

   

6. Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells

   • Yan Li
   • Jezrael L. Revalde
   • James W Paxton

   Original Article 30 November 2010 Pages: 603 - 610

   

7. Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer

   • Eishi Baba
   • Taito Esaki
   • Koichi Akashi

   Original Article 30 November 2010 Pages: 611 - 617

   

8. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer

   • Wei Yu
   • Li Chen
   • Jing Yang

   Original Article 01 December 2010 Pages: 619 - 629

   

9. A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

   • Claire L. Mitchell
   • J. P. B. O’Connor
   • G. C. Jayson

   Original Article 01 December 2010 Pages: 631 - 641

   

10. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients

    • Jonathan Hebb
    • Sarit Assouline
    • Lawrence Panasci

    Original Article 01 December 2010 Pages: 643 - 651

    

11. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients

    • Toshiaki Takahashi
    • Yukiko Nakamura
    • Nobuyuki Yamamoto

    Original Article Open access 02 December 2010 Pages: 653 - 659

    

12. Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model

    • Valerie Francescutti
    • Forough Farrokhyar
    • Kamyar Kahnamoui

    Original Article 02 December 2010 Pages: 661 - 668

13. Over-expression of MDR1 in amrubicinol-resistant lung cancer cells

    • Osamu Takakuwa
    • Tetsuya Oguri
    • Shigeki Sato

    Original Article 03 December 2010 Pages: 669 - 676

    

14. Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer

    • Hiroki Kawashima
    • Akihiro Itoh
    • Yoshiki Hirooka

    Original Article 05 December 2010 Pages: 677 - 683

    

15. Effects of endurance training on combined goserelin acetate and doxorubicin treatment–induced cardiac dysfunction

    • David S. Hydock
    • Traci L. Parry
    • Reid Hayward

    Original Article 05 December 2010 Pages: 685 - 692

    

16. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin

    • Karin Holweger
    • Hans-Peter Lipp
    • Joerg Thomas Hartmann

    Original Article 07 December 2010 Pages: 693 - 701

    

17. Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results

    • Elisabeth I. Heath
    • George R. Blumenschein Jr
    • George Wilding

    Original Article 08 December 2010 Pages: 703 - 712

18. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice

    • Pedro M. G. Soares
    • Roberto C. P. Lima-Junior
    • Marcellus H. L. P. Souza

    Original Article 14 December 2010 Pages: 713 - 720

    

19. Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid

    • Amit Khatri
    • M. Waleed Gaber
    • Mark N. Kirstein

    Original Article 16 December 2010 Pages: 721 - 731

    

20. Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors

    • T. Doi
    • H. Murakami
    • T. Sasaki

    Original Article 16 December 2010 Pages: 733 - 741

    

21. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

    • Su Jin Lee
    • Yoon La Choi
    • Young-Hyuck Im

    Original Article 18 December 2010 Pages: 743 - 751

    

22. Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

    • Eun Yoon Cho
    • Myung Hee Chang
    • Young-Hyuck Im

    Original Article 18 December 2010 Pages: 753 - 761

    

23. Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer

    • Satoshi Matsusaka
    • Mitsukuni Suenaga
    • Kiyohiko Hatake

    Original Article 18 December 2010 Pages: 763 - 768

    

24. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

    • M. Tahara
    • H. Minami
    • M. Tsukuda

    Original Article 24 December 2010 Pages: 769 - 776

    

25. Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats

    • Joel M. Reid
    • Sarah A. Buhrow
    • Matthew M. Ames

    Original Article 28 December 2010 Pages: 777 - 786

    

26. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma

    • Suzana Stojanovic
    • Ivan Popov
    • Iva Kezic

    Original Article 28 December 2010 Pages: 787 - 793

27. The slow cell death response when screening chemotherapeutic agents

    • Joseph Blois
    • Adam Smith
    • Lee Josephson

    Original Article 31 December 2010 Pages: 795 - 803

    

28. Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor

    • Paul Hamberg
    • Margaret M. Woo
    • Maja de Jonge

    Clinical Trial Report Open access 26 June 2011 Pages: 805 - 813

    

29. Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines

    • Shireen Kassam
    • Heidi Goenaga-Infante
    • Simon P. Joel

    Short Communication 26 April 2011 Pages: 815 - 821

    

30. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases

    • Pierre-Yves Cordier
    • André Nau
    • Eric Peytel

    Short Communication 08 May 2011 Pages: 823 - 826